Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay.
about
Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations.Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer.Ioncopy: an R Shiny app to call copy number alterations in targeted NGS data.Physical basis of the 'magnification rule' for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer.YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics.
P2860
Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Next-Generation Assessment of ...... Tumor Genomic Profiling Assay.
@en
Next-Generation Assessment of ...... Tumor Genomic Profiling Assay.
@nl
type
label
Next-Generation Assessment of ...... Tumor Genomic Profiling Assay.
@en
Next-Generation Assessment of ...... Tumor Genomic Profiling Assay.
@nl
prefLabel
Next-Generation Assessment of ...... Tumor Genomic Profiling Assay.
@en
Next-Generation Assessment of ...... Tumor Genomic Profiling Assay.
@nl
P2093
P2860
P1476
Next-Generation Assessment of ...... Tumor Genomic Profiling Assay.
@en
P2093
Ahmet Zehir
Dara S Ross
David M Hyman
Donavan T Cheng
Jaclyn F Hechtman
José Baselga
Khedoudja Nafa
Maria E Arcila
Michael F Berger
Pedram Razavi
P2860
P304
P356
10.1016/J.JMOLDX.2016.09.010
P577
2016-12-24T00:00:00Z